ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNXT RenovoRx Inc

1.22
-0.05 (-3.94%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
RenovoRx Inc RNXT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -3.94% 1.22 14:00:07
Open Price Low Price High Price Close Price Previous Close
1.25 1.225 1.30 1.22 1.27
more quote information »

Recent News

Date Time Source Heading
02/5/202423:00BWRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital..
18/4/202422:30BWRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity..
16/4/202422:30BWRenovoRx Highlights Recent Presentation of Clinical Data..
15/4/202422:00BWRenovoRx Closes $11.1 Million Private Placement, Providing..
08/4/202422:30BWRenovoRx Announces $11.1 Million at Market Private Placement
05/4/202423:30BWRenovoRx to Present at the Canaccord Genuity Horizons in..
13/3/202400:00BWRenovoRx to Present at the 36th Annual ROTH Conference on..
09/3/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/3/202408:05BWRenovoRx Highlights Key Leadership Promotions
13/2/202411:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:30EDGAR2Form 8-K - Current report
07/2/202400:30BWRenovoRx CEO Issues Letter to Shareholders
31/1/202411:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202410:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202410:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202401:06EDGAR2Form 8-K - Current report
30/1/202400:30BWRenovoRx Closes $6.1 Million Private Placement
24/1/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202400:30EDGAR2Form 8-K - Current report
22/12/202300:30BWRenovoRx Engages Oklahoma University (OU) Health as First..
20/12/202300:30BWRenovoRx Announces Clinical Data Abstract at the 2024..
19/12/202308:15EDGAR2Form 8-K - Current report
14/12/202300:31BWRenovoRx Files New International Patent for Novel Targeted..
28/11/202305:23EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202309:30EDGAR2Form PRE 14A - Other preliminary proxy statements
17/11/202300:35BWRenovoRx Expands Scientific Advisory Board with Appointment..
15/11/202300:30BWRenovoRx Reports Third Quarter 2023 Financial Results and..
14/11/202308:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:15EDGAR2Form 8-K - Current report
05/10/202307:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:30BWRenovoRx to Present at the ROTH MKM Healthcare Opportunities..
26/8/202306:15EDGAR2Form 8-K - Current report
17/8/202322:30EDGAR2Form 8-K - Current report
17/8/202322:30BWRenovoRx Reports Second Quarter 2023 Financial Results and..
17/8/202304:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/8/202305:57EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
31/7/202322:30BWRenovoRx to Present at the 43rd Annual Canaccord Genuity..
20/7/202322:00BWRenovoRx and Imugene Announce Collaboration to Deliver..
29/6/202323:27EDGAR2Form 8-K - Current report
29/6/202322:00BWRenovoRx Announces New Positive Interim Phase III Data..
20/6/202322:30BWRenovoRx Appoints Margaret A. Tempero, M.D., to Scientific..
12/6/202322:30BWRenovoRx Announces ROTH Capital Key Opinion Leader (KOL)..
01/6/202322:30BWRenovoRx Initiates Patient Enrollment at University of Texas..

Your Recent History

Delayed Upgrade Clock